Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-02
2006-05-02
Tate, Christopher R (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S643000, C424S279100
Reexamination Certificate
active
07037893
ABSTRACT:
Glycopeptides capable of identifying multiple sclerosis antibodies, and therefore useful as diagnostic tools or for the treatment of said pathology are described.
REFERENCES:
patent: WO9735879 (1997-10-01), None
patent: WO9957241 (1999-11-01), None
patent: WO0012126 (2000-03-01), None
patent: WO03000733 (2003-01-01), None
Web site info: www.mimotopes.com/peptides/mods.html (see attached).
U.S. Appl. No. 10/483,803, filed Jan. 2004, D'alessio et al.
Mazzucco et al., “A Synthetic Glycopeptide of Human Myelin Oligodendrocyte Glycoprotein to Detect Antibody Responses in Multiple Sclerosis and Other Neurological Diseases”, Bioorganic & Medicinal Chemistry Letters, 9, pp. 167-172, (1999).
Chelli Mario
Lolli Francesco
Papini Anna Maria
Rovero Paolo
Abelman ,Frayne & Schwab
Cordero Garcia Marcela M
Tate Christopher R
Universita' Degli Studi Di Firenze
LandOfFree
Glycopeptides, their preparation and use in the diagnosis or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycopeptides, their preparation and use in the diagnosis or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycopeptides, their preparation and use in the diagnosis or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649378